Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
The findings could potentially lead to new therapies and could stop the growth of cancers
Read Moreby Jen Brogan | May 8, 2024 | News | 0
The findings could potentially lead to new therapies and could stop the growth of cancers
Read Moreby Jen Brogan | Apr 8, 2024 | News | 0
Macmillan Cancer Support estimated that around three million people in the UK were living with cancer in 2022
Read Moreby Jen Brogan | Apr 2, 2024 | News | 0
The genetic condition affects one in 279 people in England and significantly increases cancer risk
Read Moreby Jen Brogan | Mar 28, 2024 | News | 0
The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
Read Moreby Jen Brogan | Mar 8, 2024 | News | 0
The gamma treatment also shows potential for treating patients living with neurological diseases
Read Moreby Jen Brogan | Feb 2, 2024 | News | 0
Individuals with Jewish ancestry are six times more likely to carry a genetic fault
Read Moreby Jen Brogan | Jan 23, 2024 | News | 0
The advancement could allow earlier detection of cancer in the blood and better treatment
Read Moreby John Pinching | Jan 16, 2024 | News | 0
EUR 20m to identify new targets and develop first in class drugs
Read Moreby Jen Brogan | Jan 2, 2024 | News | 0
The number of people getting tested over the last decade has increased by 133%
Read Moreby Jen Brogan | Dec 19, 2023 | News | 0
In 2020, there were over ten million deaths worldwide associated with cancer
Read Moreby Jen Brogan | Nov 21, 2023 | News | 0
SMPaeds2 aims to advance precision medicines for children with relapsed cancer
Read Moreby John Pinching | Aug 14, 2023 | News | 0
The purchased therapies concerned are Cardioxane, Totect, Ethyol and Savene
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479